2018
DOI: 10.1016/j.nbd.2018.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Chronic minocycline treatment improves hippocampal neuronal structure, NMDA receptor function, and memory processing in Fmr1 knockout mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
20
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 54 publications
2
20
0
Order By: Relevance
“…Since our study shows that these mice display abnormalities in visual perception, we investigated the link between visual perception and the achievement of a cognitive task commonly used in laboratories, the NOR test. However, since Fmr1 −/y mice present an impaired recognition memory, as widely described in the literature (Ventura et al, 2004; Pardo et al, 2017; Yan et al, 2018; Yau et al, 2018), the study of the involvement of vision in this type of test can only be based on the behavior of WT mice.…”
Section: Discussionmentioning
confidence: 99%
“…Since our study shows that these mice display abnormalities in visual perception, we investigated the link between visual perception and the achievement of a cognitive task commonly used in laboratories, the NOR test. However, since Fmr1 −/y mice present an impaired recognition memory, as widely described in the literature (Ventura et al, 2004; Pardo et al, 2017; Yan et al, 2018; Yau et al, 2018), the study of the involvement of vision in this type of test can only be based on the behavior of WT mice.…”
Section: Discussionmentioning
confidence: 99%
“…As genetic deletion of MMP-9 can also reverse FXS-associated behaviors in Fmr1 KO mice ( Bilousova et al., 2009 ; Sidhu et al., 2014 ), MMP-9 is an attractive therapeutic target to reduce sensory deficits in FXS and potentially other FXS-associated behaviors. Indeed, minocycline, which beside its antibiotic effects inhibits MMP-9, has emerged as a potential treatment for FXS ( Bilousova et al., 2009 ; Paribello et al., 2010 ; Dansie et al., 2013 ; Dziembowska et al., 2013 ; Leigh et al., 2013 ; Schneider et al., 2013 ; Rotschafer & Razak, 2014 ; Yau et al., 2018 ). In humans with FXS, minocycline can reduce MMP-9 levels, reverse auditory ERP deficits, and improve FXS-associated behaviors ( Paribello et al., 2010 ; Dziembowska et al., 2013 ; Leigh et al., 2013 ; Schneider et al., 2013 ).…”
Section: Auditory Hypersensitivity and Underlying Mechanismsmentioning
confidence: 99%
“…The time spent immobile during the last 4 min of the testing session was scored by an observer blind to the treatment conditions and presented as an indicator for depression-like behavior. Immobility was defined as any movement beyond what was needed to keep the head above the water (Yau et al, 2014, 2018).…”
Section: Methodsmentioning
confidence: 99%